Advertisement

CardioVascular and Interventional Radiology

, Volume 42, Issue 1, pp 159–159 | Cite as

Don’t Call It “Hemangioma”

  • Gernot Rott
Letter to the Editor

Dear Editor,

I read with interest the article by Akhlaghpoor et al [1] entitled “Transarterial Bleomycin–Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma.” However, I would like to comment on the term “hemangioma,” as the treated lesions obviously are not hemangiomas.

The word “hemangioma” has been used for decades and unfortunately still is widely used in everyday practice to describe several lesions, which are nowadays known to be distinct pathological entities [2].

Suitable terms, that should be applied in this regard, are defined by the International Society for the Study of Vascular Anomalies (ISSVA) and summarized in its classification for vascular anomalies, recently updated in May 2018.

Experts of the ISSVA and others assume that liver or hepatic “hemangioma” in adult is in fact not a hemangioma at all, but rather a slow-flow vascular malformation, more precisely a venous malformation [2, 3, 4, 5]. These lesions are histopathologically composed of malformed vessels, are glucose transporter 1 (GLUT 1) negative and do not undergo mitosis, and thus are vascular malformations [6].

A standardized nomenclature is critical for scientific communication and patient management, and utilizing the ISSVA approach for classification of vascular lesions is strongly recommended, not only for skin or soft tissue, but also for bone and viscera.

It is long overdue to put an end to the general incorrect use of the term “hemangioma,” also and in particular within the radiological community.

Notes

Compliance with Ethical Standards

Conflict of interest

The author declares to have no conflicts of interest.

References

  1. 1.
    Akhlaghpoor S, Torkian P, Golzarian J. Transarterial bleomycin–lipiodol embolization (B/LE) for symptomatic giant hepatic hemangioma. J Cardiovasc Interv Radiol. 2018.  https://doi.org/10.1007/s00270-018-2010-4.CrossRefGoogle Scholar
  2. 2.
    Lowe LH, Marchant TC, Rivard DC, Scherbel AJ. Vascular malformations: classification and terminology the radiologist needs to know. Semin Roentgenol. 2012;47(2):106–17.  https://doi.org/10.1053/j.ro.2011.11.002.CrossRefPubMedGoogle Scholar
  3. 3.
    Mulliken JB, Burrows PE, Fishman SJ. Treatment of visceral vascular tumors. In: Mulliken JB, Burrows PE, Fishman SJ, editors. Mulliken and Young’s vascular anomalies: hemangiomas and malformations. 2nd ed. Oxford: University Press; 2013.CrossRefGoogle Scholar
  4. 4.
    Kassarjian A, Zurakowski D, Dubois J, Paltiel HJ, Fishman SJ, Burrows PE. Infantile hepatic hemangiomas: clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol. 2004;182(3):785–95.CrossRefGoogle Scholar
  5. 5.
    Behravesh S, Yakes W, Gupta N, Naidu S, Chong BW, Khademhosseini A, Oklu R. Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther. 2016;6(6):557–69.  https://doi.org/10.21037/cdt.2016.11.10.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Kollipara R, Dinneen L, Rentas KE, Saettele MR, Patel SA, Rivard DC, Lowe LH. Current classification and terminology of pediatric vascular anomalies. Am J Roentgenol. 2013;201:1124–35.  https://doi.org/10.2214/AJR.12.105.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018

Authors and Affiliations

  1. 1.Department of RadiologyBethesda-Hospital DuisburgDuisburgGermany

Personalised recommendations